Prognostic Role of Claudin-1 Immunohistochemistry in Malignant Solid Tumors: A Meta-Analysis
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin-1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods: The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results: Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions: Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.
Abstract
Background: Although the correlation between low claudin-1 expression and worse prognosis has been reported, details on the prognostic implications of claudin-1 expression in various malignant tumors remain unclear. The present study aimed to elucidate the prognostic roles of claudin-1 immunohistochemistry (IHC) in various malignant tumors through a meta-analysis. Methods: The study included 2,792 patients from 22 eligible studies for assessment of the correlation between claudin-1 expression and survival rate in various malignant tumors. A subgroup analysis based on the specific tumor and evaluation criteria of claudin-1 IHC was conducted. Results: Low claudin-1 expression was significantly correlated with worse overall survival (OS) (hazard ratio [HR], 1.851; 95% confidence interval [CI], 1.506 to 2.274) and disease-free survival (DFS) (HR, 2.028; 95% CI, 1.313 to 3.134) compared to high claudin-1 expression. Breast, colorectal, esophageal, gallbladder, head and neck, and lung cancers, but not cervical, liver or stomach cancers, were significantly correlated with worse OS. Breast, colorectal, esophageal, and thyroid cancers with low claudin-1 expression were associated with poorer DFS. In the lower cut-off subgroup (< 25.0%) with respect to claudin-1 IHC, low claudin-1 expression was significantly correlated with worse OS and DFS. Conclusions: Taken together, low claudin-1 IHC expression is significantly correlated with worse survival in various malignant tumors. More detailed criteria for claudin-1 IHC expression in various malignant tumors are needed for application in daily practice.
참고문헌 (36)
- Colegio OR, "Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture", Am J Physiol Cell Physiol, 284, pp.C1346~C1354 (2003)
- Miwa N, "Involvement of claudin-1 in the beta-catenin", Tcf signaling pathway and its frequent upregulation in human colorectal cancers, 2001, pp.12, 469~476
- Bhat AA, "Caudal homeobox protein Cdx-2cooperates with Wnt pathway to regulate claudin-1 expression in colon cancer cells", PLoS One, 7, pp.e37174~ (2012)
- Tsukita S, "The structure and function of claudins, cell adhesion molecules at tight junctions", Ann N Y Acad Sci, 915, pp.129~135 (2000)
- Günzel D, "Claudins and other tight junction proteins", Compr Physiol, 2, pp.1819~1852 (2012)
- Krug SM, "Tight junction, selective permeability, and related diseases", Semin Cell Dev Biol, 36, pp.166~176 (2014)
- Koval M., "Claudin heterogeneity and control of lung tight junctions", Annu Rev Physiol, 75, pp.551~567 (2013)
- Capaldo CT, "Claudin switching : physiological plasticity of the tight Junction", Semin Cell Dev Biol, 42, pp.22~29 (2015)
- Huang J, "The expression of claudin 1 correlates with beta-catenin and is a prognostic factor of poor outcome in gastric cancer", Int J Oncol, 44, pp.1293~1301 (2014)
- Suh Y, "Claudin-1 induces epithelial-mesenchymal transition through activation of the c-Abl-ERK signaling pathway in human liver cells", Oncogene, 32, pp.4873~4882 (2013)
- Bouchagier KA, "Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients’ survival", In Vivo, 28, pp.315~326 (2014)
- 채민철, "Prognostic Significance of Claudin 4 in Completely Resected Adenocarcinoma of the Lung", Journal of Chest Surgery, 47(3), pp.262~268 (2014), 대한심장혈관흉부외과학회
- Chao YC, "Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma", Am J Respir Crit Care Med, 179, pp.123~133 (2009)
- Fritzsche FR, "Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas", Clin Cancer Res, 14, pp.7035~7042 (2008)
- Higashi Y, "Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma", J Surg Res, 139, pp.68~76 (2007)
- Hoellen F, "Claudin-1 expression in cervical cancer", Mol Clin Oncol, 7, pp.880~884 (2017)
- Jung H, "The expression of claudin-1, claudin-2, claudin-3, and claudin-4 in gastric cancer tissue", J Surg Res, 167, pp.e185~e191 (2011)
- Li WJ, "Expression of claudin-1 and its relationship with lymphatic microvessel generation in hypopharyngeal squamous cell carcinoma", Genet Mol Res, 14, pp.11814~11826 (2015)
- Ma F, "A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer", PLoS One, 9, pp.e112765~ (2014)
- Matsuoka T, "Cluster analysis of claudin-1and-4, E-cadherin, and beta-catenin expression in colorectal cancers", J Surg Oncol, 103, pp.674~686 (2011)
- Merikallio H, "Impact of smoking on the expression of claudins in lung carcinoma", Eur J Cancer, 47, pp.620~630 (2011)
- Miyamoto K, "Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma", Biomed Res, 29, pp.71~76 (2008)
- Morohashi S, "Decreased expression of claudin-1 correlates with recurrence status in breast cancer", Int J Mol Med, 20, pp.139~143 (2007)
- Resnick MB, "Claudin-1 is a strong prognostic indicator in stage II colonic cancer : a tissue microarray study", Mod Pathol, 18, pp.511~518 (2005)
- Sappayatosok K, "Overexpression of claudin-1 is associated with advanced clinical stage and invasive pathologic characteristics of oral squamous cell carcinoma", Head Neck Pathol, 9, pp.173~180 (2015)
- Shibutani M, "Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer", Anticancer Res, 33, pp.3301~3306 (2013)
- 신홍일, "Expression of Claudin-1 and -7 in Clear Cell Renal Cell Carcinoma and Its Clinical Significance", Investigative and Clinical Urology, 52(5), pp.317~322 (2011), 대한비뇨의학회
- Tzelepi VN, "Tight junctions in thyroid carcinogenesis : diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms", Mod Pathol, 21, pp.22~30 (2008)
- Xiong L, "Expressions of cell junction regulatory proteins and their association with clinicopathologic parameters in benign and malignant gallbladder lesions", Am J Med Sci, 342, pp.388~394 (2011)
- Yoshida T, "Decreased expression of claudin-1 in rectal cancer : a factor for recurrence and poor prognosis", Anticancer Res, 31, pp.2517~2525 (2011)
- Zhang Z, "Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma", J Cardiothorac Surg, 8, pp.95~ (2013)
- Parmar MK, "Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints", Stat Med, 17, pp.2815~2834 (1998)
- Mineta K, "Predicted expansion of the claudin multigene family", FEBS Lett, 585, pp.606~612 (2011)
- Singh AB, "Claudin-1 expression confers resistance to anoikis in colon cancer cells in a Src-dependent manner", Carcinogenesis, 33, pp.2538~2547 (2012)
- Kinugasa T, "Increased claudin-1 protein expression in hepatic metastatic lesions of colorectal cancer", Anticancer Res, 32, pp.2309~2314 (2012)
- Chang TL, "Claudin-1 has tumor suppressive activity and is a direct target of RUNX3 in gastric epithelial cells", Gastroenterology, 138, pp.255.e1-3~265.e1-3 (2010)